Determinants of human papillomavirus infection among Inuit women of northern Quebec, Canada.
暂无分享,去创建一个
[1] E. Franco,et al. Prevalence and Age Distribution of Human Papillomavirus Infection in a Population of Inuit Women in Nunavik, Quebec , 2008, Cancer Epidemiology Biomarkers & Prevention.
[2] N. Muñoz,et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. , 2007, The Lancet. Infectious diseases.
[3] E. Franco,et al. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. , 2007, Gynecologic oncology.
[4] Elizabeth R Unger,et al. Prevalence of HPV infection among females in the United States. , 2007, JAMA.
[5] L. R. Long,et al. Age-related changes of the cervix influence human papillomavirus type distribution. , 2006, Cancer research.
[6] D. Provencher,et al. Self-sampling is associated with increased detection of human papillomavirus DNA in the genital tract of HIV-seropositive women. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] S. Wacholder,et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. , 2005, The Journal of infectious diseases.
[8] S. Franceschi,et al. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[9] Xavier Castellsagué,et al. Against which human papillomavirus types shall we vaccinate and screen? the international perspective , 2004, International journal of cancer.
[10] Mark Woodward,et al. Imputations of missing values in practice: results from imputations of serum cholesterol in 28 cohort studies. , 2004, American journal of epidemiology.
[11] Claude Fauquet,et al. Classification of papillomaviruses. , 2004, Virology.
[12] M. Abrahamowicz,et al. Predictors of cervical coinfection with multiple human papillomavirus types. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[13] Michal Abrahamowicz,et al. The natural history of type-specific human papillomavirus infections in female university students. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[14] S. Franceschi,et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology , 2002, British Journal of Cancer.
[15] Lawrence Joseph,et al. Multiple Imputation to Account for Missing Data in a Survey: Estimating the Prevalence of Osteoporosis , 2002, Epidemiology.
[16] K. Aronson,et al. Oncogenic Human Papillomavirus Infection and Cervical Lesions in Aboriginal Women of Nunavut, Canada , 2001, Sexually transmitted diseases.
[17] E. Franco,et al. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[18] J. Kaczorowski,et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[19] M. Plummer,et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. , 2000, Journal of the National Cancer Institute.
[20] J. Peto,et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.
[21] A. Giuliano,et al. Risk factors for high-risk type human papillomavirus infection among Mexican-American women. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[22] K. Young,et al. Factors Associated With Human Papillomavirus Infection Detected by Polymerase Chain Reaction Among Urban Canadian Aboriginal and Non‐Aboriginal Women , 1997, Sexually transmitted diseases.
[23] N. Ramoz,et al. HLA control in the progression of human papillomavirus infections. , 1996, Seminars in cancer biology.
[24] F. Wiklund,et al. Different HLA‐DR‐DO haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type‐16 seropositive and seronegative Swedish women , 1996, International journal of cancer.
[25] C. Wheeler,et al. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. , 1995, Journal of the National Cancer Institute.
[26] W. Klitz,et al. HLA DR–DQ associations with cervical carcinoma show papillomavirus–type specificity , 1994, Nature Genetics.
[27] R. Kronmal,et al. Multiple imputation of baseline data in the cardiovascular health study. , 2003, American journal of epidemiology.
[28] J. Kaczorowski,et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[29] T. Ganesan,et al. The roles of the human major histocompatibility complex and human papillomavirus infection in cervical intraepithelial neoplasia and cervical cancer. , 1997, Clinical oncology (Royal College of Radiologists (Great Britain)).
[30] H. Storm,et al. Cancer in Circumpolar Inuit 1969-1988. A summary. , 1996, Acta oncologica.